THE ROLE OF IMAGING IN THE MANAGEMENT OF RENAL MASSES
DOI:
https://doi.org/10.53555/nnmhs.v8i1.1161Keywords:
Renal neoplasm, Renal cell carcinoma, Multimodal imaging, Minimally invasive treatmentAbstract
The widespread availability of cross-sectional imaging is responsible for the increased detection of small, usually asymptomatic renal masses. More than 50% of renal cell carcinomas (RCCs) represent incidental findings on noninvasive imaging. Multimodality imaging, including conventional US, contrast-enhanced US (CEUS), multiparametric CT and MRI (mpMRI) is essential in diagnosing and characterizing renal masses, but also provides information regarding its prognosis, therapeutic management, and follow-up. In this review, the imaging data for renal masses that urologists require for accurate treatment planning will be discussed. The roles of US, CEUS, CT and mpMRI in the detection and characterization of renal masses, RCC staging and follow-up of treated or untreated local RCCs will be presented. The role of percutaneous image-guided ablation in the management of RCC will also be reviewed.
References
M. Jayson, H. Sanders, Increased incidence of serendipitously discovered renal cell carcinoma, Urology 51 (1998) 203–205, https://doi.org/10.1016/s0090- 4295(97)00506-2.
B. Ljungberg, L. Albiges, Y. Abu-Ghanem, K. Bensalah, S. Dabestani, S. Fernandez-Pello, ´ RH Giles, F. Hofmann, M. Hora, MA Kuczyk, T. Kuusk, TB Lam, L. Marconi, AS Merseburger, T. Powles, M. Staehler, R. Tahbaz, A. Volpe, A. Bex, European association of urology guidelines on renal cell carcinoma: the 2019 update, Eur. Urol. 75 (2019) 799– 810, https://doi.org/ 10.1016/j.eururo.2019.02.011.
S. Campbell, RG Uzzo, ME Allaf, EM Remer, Renal Mass and Localized Renal Cancer: AUA Guideline, J. Urol. 198 (2017) 520–529, https://doi.org/10.1016/j. juro.2017.04.100.
RD Ward, H. Tanaka, SC Campbell, EM Remer, 2017 AUA renal mass and localized renal Cancer guidelines: imaging implications, Radiographics 38 (2018) 2021–2033, https://doi.org/10.1148/rg.2018180127.
BR Herts, SG Silverman, NM Hindman, RG Uzzo, RP Hartman, GM Israel, DA Baumgarten,
a. LL Berland, PV Pandharipande, Management of the Incidental Renal Mass on CT: A White Paper of the ACR Incidental Findings Committee, J. Am. Coll. Radiol. 15 (2018) 264–273, https://doi.org/10.1016/j. jacr.2017.04.028.
Expert Panel on Urologic Imaging, ZJ Wang, P. Nikolaidis, G. Khatri, VS Dogra, D. Ganeshan, S. Goldfarb, JL Gore, RT Gupta, RP Hartman, ME Heilbrun, A. Lyshchik, AS Purysko, SJ Savage, AD Smith, DJ Wolfman, JJ Wong-YouCheong, ME Lockhart, ACR appropriateness criteria® indeterminate renal mass, J. Am. Coll. Radiol. 17 (2020) S415– S428, https://doi.org/10.1016/j. jacr.2020.09.010.
FU Kay, I. Pedrosa, Imaging of solid renal masses, Urol. Clin. North Am. 45 (2018) 311– 330, https://doi.org/10.1016/j.ucl.2018.03.013.
E. Guðmundsson, H. Hellborg, S. Lundstam, S. Erikson, B. Ljungberg, Metastatic potential in renal cell carcinomas ≤7cm: swedish kidney Cancer quality register data, Eur. Urol. 60 (2011) 975–982, https://doi.org/10.1016/j. eururo.2011.06.029.
A. Volpe, T. Panzarella, RA Rendon, MA Haider, FI Kondylis, MAS Jewett, The natural history of incidentally detected small renal masses, Cancer 100 (2004) 738–745, https://doi.org/10.1002/cncr.20025.
KH Tsui, O. Shvarts, RB Smith, R. Figlin, JB de Kernion, A. Belldegrun, Renal cell carcinoma: prognostic significance of incidentally detected tumors, J. Urol. 163 (2000) 426– 430, https://doi.org/10.1016/s0022-5347(05)67892-5.
JJ Patard, A. Rodriguez, N. Rioux-Leclercq, F. Guille, B. Lobel, Prognostic significance of the mode of detection in renal tumours, BJU Int. 90 (2002) 358–363, https://doi.org/10.1046/j.1464-410x.2002.02910.x.
SG Silverman, I. Pedrosa, JH Ellis, NM Hindman, N. Schieda, AD Smith, EM Remer, AB Shinagare, NE Curci, SS Raman, SA Wells, SD Kaffenberger, ZJ Wang, H. Chandarana, MS Davenport, Bosniak classification of cystic renal masses, version 2019: an update proposal and needs assessment, Radiology 292 (2019) 475–488, https://doi.org/10.1148/radiol.2019182646.
S. Krishna, N. Schieda, I. Pedrosa, N. Hindman, RH Baroni, SG Silverman, MS Davenport, Update on MRI of cystic renal masses including bosniak version 2019, J. Magn. Reson. Imaging 2 (2020), https://doi.org/10.1002/jmri.27364
R. Vikram, MD Beland, MD Blaufox, CC Moreno, JL Gore, HJ Harvin, ME Heilbrun, SL Liauw, PL Nguyen, P. Nikolaidis, GM Preminger, AS Purysko, SS Raman, MT Taffel, ZJ Wang, RM Weinfeld, EM Remer, ME Lockhart, ACR appropriateness criteria renal cell carcinoma staging, J. Am. Coll. Radiol. 13 (2016) 518–525, https://doi.org/10.1016/j.jacr.2016.01.021.
American Joint Committee on Cancer Kidney, MB Amin, S. Edge, F. Greene, et al. (Eds.), AJCC Cancer Staging Manual, 8th ed, Springer-Verlag, New York, NY, 2017, pp. 747–756.
H. Moch, AL Cubilla, PA Humphrey, VE Reuter, TM Ulbright, The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours, Eur. Urol. 70 (2016) 93–105, https://doi. org/10.1016/j.eururo.2016.02.029.
B. Delahunt, JC Cheville, G. Martignoni, PA Humphrey, C. Magi-Galluzzi, J. McKenney,
a. L. Egevad, F. Algaba, H. Moch, DJ Grignon, R. Montironi, JR Srigley, Members of the ISUP Renal Tumor Panel, the International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters, Am. J. Surg. Pathol. 37 (2013) 1490–1504, https://doi. org/10.1097/PAS.0b013e318299f0fb.
Expert Panel on Urological Imaging, AS Purysko, P. Nikolaidis, VS Dogra, D. Ganeshan, JL Gore, RT Gupta, ME Heilbrun, G. Khatri, AU Kishan, A. Lyshchik, SJ Savage, AD Smith, ZJ Wang, DJ Wolfman, JJ Wong-YouCheong, DC Yoo, ME Lockhart, ACR appropriateness criteria post-treatment follow-up and active surveillance of clinically localized renal cell Cancer, J. Am. Coll. Radiol. 16 (2019) S399–S416, https://doi.org/10.1016/j.jacr.2019.05.022.
K. Katsanos, L. Mailli, M. Krokidis, A. McGrath, T. Sabharwal, A. Adam, Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours, Cardiovasc. Intervent. Radiol. 37 (2014) 427–437, https://doi.org/10.1007/s00270014-0846-9.
ME Krokidis, F. Orsi, K. Katsanos, T. Helmberger, A. Adam, CIRSE guidelines on percutaneous ablation of small renal cell carcinoma, Cardiovasc. Intervent. Radiol. 40 (2017) 177–191, https://doi.org/10.1007/s00270-016-1531-y.
M. Borghesi, E. Brunocilla, A. Volpe, H. Dababneh, CV Pultrone, V. Vagnoni, G. La Manna, A. Porreca, G. Martorana, R. Schiavina, Active surveillance for clinically localized renal tumors: An updated review of current indications and clinical outcomes, Int. J. Urol. 22 (2015) 432–438, https://doi.org/10.1111/ iju.12734.
M. Nayyar, P. Cheng, B. Desai, S. Cen, M. Desai, I. Gill, V. Duddalwar, Active surveillance of small renal masses: a review on the role of imaging with a focus on growth rate, J.
a. Comput. Assist. Tomogr. 40 (2016) 517–523, https://doi.org/
b. 10.1097/RCT.0000000000000407.
B. Musaddaq, T. Musaddaq, A. Gupta, S. Ilyas, C. von Stempel, Renal cell carcinoma: the evolving role of imaging in the 21st century, Semin. Ultrasound CT MR 41 (2020) 344–350, https://doi.org/10.1053/j.sult.2020.05.002.
R. Kaur, M. Juneja, AK Mandal, An overview of non-invasive imaging modalities for diagnosis of solid and cystic renal lesions, Med. Biol. Eng. Comput. 58 (2020) 1–24, https://doi.org/10.1007/s11517-019-02049-z.
P. Pavlica, L. Derchi, G. Martorana, E. Brunocilla, A. Bertaccini, F. Manferrari, A. Franceschelli, L. Barozzi, Renal cell carcinoma imaging, Eur. Urol. Sup. 5 (2006) 580–592, https://doi.org/10.1016/j.eursup.2006.03.010.
M. Bertolotto, S. Bucci, M. Valentino, F. Curro, ` C. Sachs, MA Cova, Contrastenhanced ultrasound for characterizing renal masses, Eur. J. Radiol. 105 (2018) 41–48, https://doi.org/10.1016/j.ejrad.2018.05.015.
M. Siddaiah, S. Krishna, MDF McInnes, JS Quon, WM Shabana, D. Papadatos, N. Schieda, Is Ultrasound Useful for Further Evaluation of Homogeneously Hyperattenuating Renal Lesions Detected on CT? AJR Am. J. Roentgenol. 209 (2017) 604–610, https://doi.org/10.2214/AJR.17.17814.
CM Burgan, R. Rupan Sanyal, ME Lockhart, Ultrasound of renal masses, Radiol. Clin. North Am. 57 (2019) 585–600, https://doi.org/10.1016/j.rcl.2019.01.009.
PS Sidhu, V. Cantisani, CF Dietrich, OH Gilja, A. Saftoiu, E. Bartels, M. Bertolotto, F.
a. Calliada, D. Clevert, D. Cosgrove, A. Deganello, M. D'Onofrio, FM Drudi, S. Freeman, C. Harvey, C. Jenssen, E. Jung, AS Klauser, N. Lassau, MF Meloni, E. Leen, C. Nicolau, C. Nolsoe, F. Piscaglia, F. Prada, H. Prosch, M. Radzina, L. Savelli, H. Weskott, H. Wijkstra,
b. The EFSUMB Guidelines and Recommendations for the Clinical Practice of ContrastEnhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version), Ultraschall Med. 39 (2018) e2–e44, https://doi.org/10.1055/s-0044-101254.
TJ van Oostenbrugge, JJ Fütterer, PFA Mulders, Diagnostic imaging for solid renal tumors: a pictorial review, Kidney Cancer 2 (2018) 79–93, https://doi.org/ 10.3233/KCA-180028.
C. Lopes Vendrami, CP Villavicencio, TJ DeJulio, A. Chatterjee, DD Casalino, JM Horowitz, DT Oberlin, G. Yang, P. Nikolaidis, FH Miller, Differentiation of solid renal tumors with Multiparametric MR imaging, Radiographics 37 (2017) 2026–2042, https://doi.org/10.1148/rg.2017170039.
F. Cornelis, N. Grenier, Multiparametric magnetic resonance imaging of solid renal tumors: a practical algorithm, Semin. Ultrasound CT MR 38 (2017) 47–58, https://doi.org/10.1053/j.sult.2016.08.009.
L. Marconi, S. Dabestani, TB Lam, F. Hofmann, F. Stewart, J. Norrie, A. Bex, K. Bensalah, SE Canfield, M. Hora, MA Kuczyk, AS Merseburger, PFA Mulders, T. Powles, M. Staehler, B. Ljungberg, A. Volpe, Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy, Eur. Urol. 69 (2016) 660–673, https://doi.org/10.1016/j.eururo.2015.07.072.
N. Shi, F. Zu, Y. Shan, S. Chen, B. Xu, M. Du, M. Chen, The value of renal score in both determining surgical strategies and predicting complications for renal cell carcinoma: a systematic review and meta-analysis, Cancer Med. 9 (2020) 3944–3953, https://doi.org/10.1002/cam4.2993.
SM Lee, I. Robertson, T. Stonier, N. Simson, T. Amer, OM Aboumarzouk, Contemporary outcomes and prediction of adherent perinephric fat at partial nephrectomy: a systematic review, Scand. J. Urol. 51 (2017) 429–434, https:// doi.org/10.1080/21681805.2017.1357656.
N. Alsaikhan, W. Alshehri, F. Cassidy, L. Aganovic, N. Vahdat, Renal tumor structured reporting including nephrometry score and beyond: what the urologist and interventional radiologist need to know, Abdom. Radiol. (NY) 44 (2019) 190–200, https://doi.org/10.1007/s00261-018-1691-0.
A. Nilsson, Contrast-enhanced ultrasound of the kidneys, Eur. Radiol. 14 (2004) P104–109.
JM Correas, M. Claudon, F. Tranquart, O. H´el´enon, The kidney: imaging with microbubble contrast agents, Ultrasound Q. 22 (2006) 53–66.
CJ Harvey, A. Alsafi, S. Kuzmich, A. Ngo, I. Papadopoulou, A. Lakhani, Y. Berkowitz, S. Moser, PS Sidhu, DO Cosgrove, Role of US contrast agents in the assessment of indeterminate solid and cystic lesions in native and transplant kidneys, Radiographics 35 (2015) 1419–1430, https://doi.org/10.1148/ rg.2015140222.
A. Ignee, B. Straub, G. Schuessler, CF Dietrich, Contrast enhanced ultrasound of renal masses, World J. Radiol. 28 (2010) 15–31, https://doi.org/10.3233/CH2010-1352.
DD Cokkinos, EG Antypa, M. Skilakaki, D. Kriketou, E. Tavernaraki, PN Piperopoulos, Contrast Enhanced Ultrasound of the Kidneys: What Is It Capable of? Biomed. Res. Int. (2013) 595873, https://doi.org/10.1155/2013/ 595873.
S. Mazziotti, F. Zimbaro, A. Pandolfo, S. Racchiusa, N. Settineri, G. Ascenti, Usefulness of contrast-enhanced ultrasonography in the diagnosis of renal pseudotumors, Abdom. Imaging 35 (2010) 241–245, https://doi.org/10.1007/ s00261-008-9499-y.
TH Oh, YH Lee, IY Seo, Diagnostic efficacy of contrast-enhanced ultrasound for small renal masses, Korean J. Urol. 55 (2014) 587–592, https://doi.org/ 10.4111/kju.2014.55.9.587.
ZF Xu, HX Xu, XY Xie, GJ Liu, YL Zheng, MD Lu, Renal cell carcinoma and renal angiomyolipoma: differential diagnosis with real-time contrast-enhanced ultrasonography, J. Ultrasound Med. 29 (2010) 709–717, https://doi.org/ 10.7863/jum.2010.29.5.709.
ZF Xu, HX Xu, XY Xie, GJ Liu, YL Zheng, JY Liang, MD Lu, Renal cell carcinoma: realtime contrast-enhanced ultrasound findings, Abdom. Imaging 35 (2010) 750–756, https://doi.org/10.1007/s00261-009-9583-y.
M. Atri, L. Tabatabaeifar, HJ Jang, A. Finelli, H. Moshonov, M. Jewett, Accuracy of contrast-enhanced US for differentiating benign from malignant solid small renal masses, Radiology 276 (2015) 900–908, https://doi.org/10.1148/ radiol.2015140907.
DA Clevert, N. Minaifar, S. Weckbach, EM Jung, K. Stock, M. Reiser, M. Staehler, Multislice computed tomography versus contrast-enhanced ultrasound in evaluation of complex cystic renal masses using the Bosniak classification system, Clin. Hemorheol. Microcirc. 39 (2008) 171–178.
BK Park, B. Kim, SH Kim, K. Ko, HM Lee, HY Choi, Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US, Eur. J. Radiol. 61 (2007) 310–314, https://doi.org/10.1016/j. ejrad.2006.10.004.
G. Ascenti, S. Mazziotti, G. Zimbaro, N. Settineri, C. Magno, D. Melloni, R. Caruso, E. Scribano, Complex cystic renal masses: characterization with contrastenhanced US, Radiology 243 (2007) 158–165, https://doi.org/10.1148/ radiol.2431051924.
E. Quaia, M. Bertolotto, V. Cioffi, A. Rossi, E. Baratella, R. Pizzolato, MA Cova, Comparison of contrast-enhanced sonography with unenhanced sonography and contrastenhanced CT in the diagnosis of malignancy in complex cystic renal masses, AJR Am. J. Roentgenol. 191 (2008) 1239–1249, https://doi.org/ 10.2214/AJR.07.3546.
O. Graumann, SS Osther, J. Karstoft, A. Horlyck, PJ Osther, Bosniak classification system: a prospective comparison of CT, contrast-enhanced US, and MR for categorizing complex renal cystic masses, Acta Radiol. 57 (2016) 1409–1417, https://doi.org/10.1177/0284185115588124.
EH Chang, WK Chong, SK Kasoji, JR Fielding, E. Altun, LB Mullin, JI Kim, JP Fine, PA Dayton, WK Rathmell, Diagnostic accuracy of contrast-enhanced ultrasound for characterization of kidney lesions in patients with and without chronic kidney disease, BMC Nephrol. 18 (2017) 266, https://doi.org/10.1186/ s12882-017-0681-8.
M. Gulati, KG King, IS Gill, V. Pham, E. Grant, VA Duddalwar, Contrastenhanced ultrasound (CEUS) of cystic and solid renal lesions: a review, Abdom. Imaging 40 (2015) 1982–1996, https://doi.org/10.1007/s00261-015-0348-5.
M. Bertolotto, C. Cicero, R. Perrone, F. Degrassi, F. Cacciato, MA Cova, Renal masses with equivocal enhancement at CT: characterization with contrastenhanced ultrasound, AJR Am. J. Roentgenol. 204 (2015) W557–W565, https:// doi.org/10.2214/AJR.14.13375.
RG Barr, C. Peterson, A. Hindi, Evaluation of indeterminate renal masses with contrastenhanced US: a diagnostic performance study, Radiology 271 (2013) 133–142, https://doi.org/10.1148/radiol.13130161.
CJ Harvey, A. Alsafi, S. Kuzmich, A. Ngo, I. Papadopoulou, A. Lakhani, Y. Berkowitz, S. Moser, PS Sidhu, DO Cosgrove, Role of US contrast agents in the assessment of indeterminate solid and cystic lesions in native and transplant kidneys, Radiographics 35 (2015) 1419–1430, https://doi.org/10.1148/ rg.2015140222. AC Tsili et al. European Journal of Radiology 141 (2021) 109777 12
Q. Li, Z. Wang, X. Ma, J. Tang, Y. Luo, Diagnostic accuracy of contrast-enhanced ultrasound for detecting bland thrombus from inferior vena cava tumor thrombus in patients with renal cell carcinoma, Int. Braz. J. Urol. 46 (2020) 92–100, https://doi.org/10.1590/S1677-5538.IBJU.2019.0304.
MF Meloni, M. Bertolotto, C. Alberzoni, S. Lazzaroni, C. Filice, T. Livraghi, G. Ferraioli,
Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrastenhanced sonography versus contrast-enhanced CT or MRI, AJR Am. J. Roentgenol. 191 (2008) 1233–1238, https://doi.org/10.2214/ AJR.07.3238.
SC Tenant, CM Gutteridge, The clinical use of contrast-enhanced ultrasound in the kidney, Ultrasound 24 (2016) 94–103, https://doi.org/10.1177/ 1742271X15627185.
ML Schnitzer, L. Sabel, V. Schwarze, C. Marschner, MF Froelich, P. Nuhn, Y. Falck, MM Nuhn, S. Afat, M. Staehler, J. Rückel, D.-A. Clevert, J. Rübenthaler, T. Geyer, Structured reporting in the characterization of renal cysts by contrastenhanced ultrasound (CEUS) using the bosniak classification systemimprovement of report quality and interdisciplinary communication, Diagnostics (Basel) 11 (2021) 313, https://doi.org/10.3390/diagnostics11020313.
V. Schwarze, J. Rübenthaler, C. Marschner, MP Fabritius, J. Rueckel, N. Fink, D. PuhrWesterheide, E. Gresser, MF Froelich, ML Schnitzer, N. Große Hokamp, S. Afat, M.
a. Staehler, T. Geyer, D.-A. Clevert, Advanced fusion imaging and contrast-enhanced imaging (CT/MRI–CEUS) in oncology, Cancers 12 (2020) 2821, https://doi.org/10.3390/cancers12102821.
P. Frinking, T. Segers, Y. Luan, FC Tranquart, Three decades of ultrasound contrast agents:
a. a review of the past, present and future improvements, Ultrasound Med. Biol. 46 (2020) 892–908, https://doi.org/10.1016/j. ultrasmedbio.2019.12.008.
K. Sasaguri, N. Takahashi, CT and MR imaging for solid renal mass characterization, Eur. J. Radiol. 99 (2018) 40–54, https://doi.org/10.1016/j. ejrad.2017.12.008.
ZJ Wang, AC Westphalen, RJ Zagoria, CT and MRI of small renal masses, Br. J. Radiol. 91 (2018) 20180131, https://doi.org/10.1259/bjr.20180131.
S. Krishna, CA Murray, MD McInnes, R. Chatelain, M. Siddaiah, O. Al-Dandan, S.
a. Narayanasamy, N. Schieda, CT imaging of solid renal masses: pitfalls and solutions, Clin. Radiol. 72 (2017) 708–721, https://doi.org/10.1016/j. crad.2017.05.003.
ZJ Wang, MS Davenport, SG Silverman, H. Chandarana, A. Doshi, GM Israel, JR Leyendecker, I. Pedrosa, S. Raman, EM Remer, AB Shinagare, AD Smith, R. Vikram, CT Renal Mass Protocol v1.0: Society of Abdominal Radiology Disease Focused Panel on Renal Cell Carcinoma, 2020 https://doi.org/ abdominalradiology.org/wpcontent/uploads/2020/11/RCC.CTprotocolsfinal-7- 15-17.pdf.
BA Birnbaum, JE Jacobs, P. Ramchandani, Multiphasic renal CT: comparison of renal mass enhancement during the corticomedullary and nephrographic phases, Radiology 200 (1996) 753–758, https://doi.org/10.1148/ radiology.200.3.8756927.
ND Egbert, EM Caoili, RH Cohan, MS Davenport, IR Francis, LP Kunju, JH Ellis, Differentiation of papillary renal cell carcinoma subtypes on CT and MRI, AJR Am. J. Roentgenol. 201 (2013) 347–355, https://doi.org/10.2214/ AJR.12.9451.
RD Ward, EM Remer, Cystic renal masses: an imaging update, Eur. J. Radiol. 99 (2017) 103–110, https://doi.org/10.1016/j.ejrad.2017.12.015.
S. Narayanasamy, S. Krishna, AK Prasad Shanbhogue, TA Flood, N. Sadoughi, P. Sathiadoss, N. Schieda, Contemporary update on imaging of cystic renal masses with histopathological correlation and emphasis on patient management, Clin. Radiol. 74 (2019) 83–94, https://doi.org/10.1016/j.crad.2018.09.003.
N. Schieda, MS Davenport, S. Krishna, EA Edney, I. Pedrosa, N. Hindman, RH Baroni, NE Curci, A. Shinagare, SG Silverman, Bosniak classification of cystic renal masses, version 2019: a pictorial guide to clinical use, Radiographics 16 (2021) 200160, https://doi.org/10.1148/rg.2021200160.
E. Edney, MS Davenport, N. Curci, N. Schieda, S. Krishna, N. Hindman, SG Silverman, I. Pedrosa, Bosniak classification of cystic renal masses, version 2019: interpretation pitfalls and recommendations to avoid misclassification, Abdom. Radiol. (NY) 23 (2021), https://doi.org/10.1007/s00261-020-02906-8.
BA Birnbaum, N. Hindman, J. Lee, JS Babb, Renal cyst pseudoenhancement: influence of multidetector CT reconstruction algorithm and scanner type in phantom model, Radiology 244 (2007) 767–775, https://doi.org/10.1148/ radiol.2443061537.
JH Kim, HY Sun, J. Hwang, SS Hong, YJ Cho, SW Doo, WJ Yang, YS Song, Diagnostic accuracy of contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging of small renal masses in real practice: sensitivity and specificity according to subjective radiologic interpretation, World J. Surg. Oncol. 12 (2016) 260, https://doi.org/10.1186/ s12957-016-1017-z.
T. Kwon, IG Jeong, S. Yoo, SJ Lee, S. Hong, D. You, JH Hong, H. Ahn, C. Kim, Role of
a. MRI in indeterminate renal mass: diagnostic accuracy and impact on clinical decision making, Int. Urol. Nephrol. 47 (2015) 585–593, https://doi.org/ 10.1007/s11255-015-0928x.
J. Patel, MS Davenport, S. Khalatbari, RH Cohan, JH Ellis, JF Platt, In vivo predictors of renal cyst pseudoenhancement at 120 kVp, AJR Am. J. Roentgenol. 202 (2014) 336–342, https://doi.org/10.2214/AJR.13.10915.
NS Patel, L. Poder, ZJ Wang, BM Yeh, A. Qayyum, H. Jin, FV Coakley, The characterization of small hypoattenuating renal masses on contrast-enhanced CT, Clin. Imaging 33 (2009) 295–300, https://doi.org/10.1016/j. clinimag.2008.12.002.
GM Israel, MA Bosniak, Pitfalls in renal mass evaluation and how to avoid them, Radiographics 28 (2008) 1325–1338, https://doi.org/10.1148/ rg.285075744.
KZ Sheir, M. El-Azab, A. Mosbah, M. El-Baz, AA Shaaban, Differentiation of renal cell carcinoma subtypes by multislice computerized tomography, J. Urol. 174 (2005) 451–455, https://doi.org/10.1097/01.ju.0000165341.08396.a9.
JR Young, D. Margolis, S. Sauk, AJ Pantuck, J. Sayre, SS Raman, Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT, Radiology 267 (2013) 444–453, https://doi.org/10.1148/radiol.13112617.
JK Kim, SY Park, JH Shon, KS Cho, Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT, Radiology 230 (2004) 677–684, https://doi.org/10.1148/radiol.2303030003.
AB Rosenkrantz, N. Hindman, EF Fitzgerald, BE Niver, J. Melamed, JS Babb, MRI features of renal oncocytoma and chromophobe renal cell carcinoma, AJR Am. J. Roentgenol. 195 (2010) W421–W427, https://doi.org/10.2214/ AJR.10.4718.
S. Choudhary, A. Rajesh, NJ Mayer, KA Mulcahy, A. Haroon, Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms, Clin. Radiol. 64 (2009) 517–522, https://doi.org/10.1016/j. crad.2008.12.011.
G. Gakis, U. Kramer, D. Schilling, S. Kruck, A. Stenzl, HP Schlemmer, Small renal oncocytomas: differentiation with multiphase CT, Eur. J. Radiol. 80 (2011) 274–278, https://doi.org/10.1016/j.ejrad.2010.06.049.
D. Giambelluca, S. Pellegrino, M. Midiri, G. Salvaggio, The "central stellate scar" sign in renal oncocytoma, Abdom. Radiol. (NY) 44 (2019) 1942–1943, https:// doi.org/10.1007/s00261-019-01899-3.
JI Kim, JY Cho, KC Moon, HJ Lee, SH Kim, Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma, Radiol 252 (2009) 441– 448, https://doi.org/10.1148/ radiol.2522081180.
N. Schieda, M. Al-Subhi, TA Flood, M. El-Khodary, MDF McInnes, Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrastenhanced magnetic resonance imaging (MRI), Eur. Radiol. 24 (2014) 2787–2794, https://doi.org/10.1007/s00330-014-3310-y.
CG Moldovanu, B. Petresc, A. Lebovici, A. Tamas-Szora, M. Suciu, N. Crisan, P. Medan, MM Buruian, Differentiation of clear cell renal cell carcinoma from other renal cell carcinoma subtypes and benign oncocytoma using quantitative MDCT enhancement parameters, Medicina (Kaunas) 28 (2020) 569, https://doi. org/10.3390/medicina56110569. 89] BK Park, Renal Angiomyolipoma: Radiologic Classification and Imaging Features According to the Amount of Fat, AJR Am. J. Roentgenol. 209 (2017) 826–835, https://doi.org/10.2214/AJR.17.17973.
N. Takahashi, S. Leng, K. Kitajima, D. Gomez-Cardona, P. Thapa, RE Carter, BC Leibovich, K. Sasiwimonphan, K. Sasaguri, A. Kawashima, Small (< 4 cm) renal masses: differentiation of angiomyolipoma without visible fat from renal cell carcinoma using unenhanced and contrast-enhanced CT, AJR Am. J. Roentgenol. 205 (2015) 1194–1202, https://doi.org/10.2214/AJR.14.14183.
SG Silverman, GM Israel, QD Trinh, Incompletely characterized incidental renal masses: emerging data support conservative management, Radiology 275 (2015) 28–42, https://doi.org/10.1148/radiol.14141144.
J. Salameh, MDF McInnes, TA McGrath, G. Salameh, N. Schieda, Diagnostic accuracy of dual-energy CT for evaluation of renal masses: systematic review and meta-analysis, AJR Am. J. Roentgenol. 212 (2019) W100–W105, https://doi.org/ 10.2214/AJR.18.20527.
D. Marin, D. Davis, KR Choudhury, B. Patel, RT Gupta, A. Mileto, RC Nelson, Characterization of small focal renal lesions: diagnostic accuracy with singlephase contrastenhanced dual-energy CT with material attenuation analysis compared with conventional attenuation measurements, Radiology 284 (2017) 737–747, https://doi.org/10.1148/radiol.2017161872.
FG Mazzei, MA Mazzei, NC Squitieri, C. Pozzessere, L. Righi, A. Cirigliano, S. Guerrini, D. D'Elia, MR Ambrosio, A. Barone, MT del Vecchio, L. Volterrani, CT perfusion in the characterization of renal lesions: an added value to multiphasic CT, Biomed Res. Int. 2014 (2014), 135013, https://doi.org/10.1155/ 2014/135013.
Z. Feng, Q. Shen, Y. Li, Z. Hu, CT texture analysis: a potential tool for predicting the Fuhrman grade of clear-cell renal carcinoma, Cancer Imaging 19 (2019) 6, https://doi.org/10.1186/s40644-019-0195-7.
Y. Deng, E. Soule, A. Samuel, S. Shah, E. Cui, M. Asare-Sawiri, C. Sundaram, C. Lall, K. Sandrasegaran, CT texture analysis in the differentiation of major renal cell carcinoma subtypes and correlation with Fuhrman grade, Eur. Radiol. 29 (2019) 6922–6929, https://doi.org/10.1007/s00330-019-06260-2.
J. Shu, Y. Tang, J. Cui, R. Yang, X. Meng, Z. Cai, J. Zhang, W. Xu, D. Wen, H. Yin, Clear cell renal cell carcinoma: CT-based radiomics features for the prediction of Fuhrman grade, Eur. J. Radiol. 109 (2018) 8–12, https://doi.org/10.1016/j. ejrad.2018.10.005.
A. Bhandari, M. Ibrahim, C. Sharma, R. Liong, S. Gustafson, M. Prior, CT-based radiomics for differentiating renal tumours: a systematic review, Abdom. Radiol. (NY) 2 (2020), https://doi.org/10.1007/s00261-020-02832-9.
MG Lubner, Radiomics and artificial intelligence for renal mass characterization, Radiol. Clin. North Am. 58 (2020) 995–1008, https://doi.org/10.1016/j. rcl.2020.06.001.
A. Finelli, N. Ismaila, B. Bro, P. Russo, Management of small renal masses: american society of clinical oncology clinical practice guideline, J. Clin. Oncol. 35 (2017) 668–680, https://doi.org/10.1200/JOP.2016.019620. AC Tsili et al. European Journal of Radiology 141 (2021) 109777 13
A. Vasudevan, RJ Davies, BA Shannon, RJ Cohen, Incidental renal tumours: the frequency of benign lesions and the role of preoperative core biopsy, BJU Int. 97 (2006) 946–949, https://doi.org/10.1111/j.1464-410X.2006.06126.x.
A. Sanchez, AS Feldman, A. Ari Hakimi, Current management of small renal masses, including patient selection, renal tumor biopsy, active surveillance, and thermal ablation, J. Clin. Oncol. 36 (2018) 3591–3600, https://doi.org/10.1200/ JCO.2018.79.2341.
K. Nakashima, Y. Kitagawa, K. Izumi, A. Mizokami, T. Gabata, M. Namiki, Diagnostic accuracy of pre-operative imaging findings in presumed clinical T1a renal cell carcinomas, Oncol. Lett. 11 (2016) 3189–3193, https://doi.org/ 10.3892/ol.2016.4330.
AJ Bradley, L. MacDonald, S. Whiteside, RJ Johnson, VAC Ramani, Accuracy of preoperative CT T staging of renal cell carcinoma: which features predict advanced stage? Clin. Radiol. 70 (2015) 822–829, https://doi.org/10.1016/j. crad.2015.03.013.
W. Chen, L. Wang, Q. Yang, B. Liu, Y. Sun, Comparison of radiographic and pathologic sizes of renal tumors, Int. Braz. J. Urol. 39 (2013) 189–194, https:// doi.org/10.1590/S16775538.IBJU.2013.02.06.
SE Lee, WK Lee, DS Kim, SH Doo, HZ Park, CY Yoon, SI Hwang, HJ Lee, G. Choe, SK Hong, Comparison of radiographic and pathologic sizes of renal tumors, World J. Urol. 28 (2010) 263–267, https://doi.org/10.1007/s00345-010- 0511-0.
C. Catalano, F. Fraioli, A. Laghi, A. Napoli, F. Pediconi, M. Danti, P. Nardis, R. Passariello, High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma, AJR Am. J. Roentgenol. 180 (2003) 1271–1277, https://doi.org/10.2214/ajr.180.5.1801271.
HK Sokhi, WY Mok, U. Patel, Stage T3a renal cell carcinoma: staging accuracy of CT for sinus fat, perinephric fat or renal vein invasion, Br. J. Radiol. 88 (2015) 20140504, https://doi.org/10.1259/bjr.20140504.
PJ Hallscheidt, M. Bock, G. Riedasch, I. Zuna, SO Schoenberg, F. Autschbach, M. Soder, G. Noeldge, Diagnostic accuracy of staging renal cell carcinomas using multidetector-row computed tomography and magnetic resonance imaging: a prospective study with histopathologic correlation, J. Comput. Assist. Tomogr. 28 (2004) 333–339, https://doi.org/10.1097/00004728-200405000-00005.
PJ Hallscheidt, C. Fink, A. Haferkamp, M. Bock, A. Luburic, I. Zuna, G. Noeldge, G. Kauffmann, Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multi- detector CT and MRI: prospective study with histopathological correlation, J. Comput. Assist. Tomogr. 29 (2005) 64–68, https://doi.org/10.1097/01.rct.0000146113.56194.6d.
N. Lawrentschuk, J. Gani, R. Riordan, S. Esler, DM Bolton, Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review, BJU Int. 96 (2005) 291–295, https://doi.org/10.1111/j.1464-410X.2005.05617.x.
Y. Sawai, T. Kinouchi, M. Mano, N. Meguro, O. Maeda, M. Kuroda, M. Usami, Ipsilateral adrenal involvement from renal cell carcinoma: retrospective study of the predictive value of computed tomography, Urology 59 (2002) 28–31, https:// doi.org/10.1016/s00904295(01)01480-7.
GJ Nason, A. Aslam, SK Giri, Predictive ability of preoperative CT scan in determining whether the adrenal gland is spared at radical nephrectomy, Curr. Urol. 9 (2016) 143–147, https://doi.org/10.1159/000442869.
S. Sheth, JC Scatarige, KM Horton, FM Corl, EK Fishman, Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector ct and three-dimensional CT,
a. Radiographics 21 (2001) S237–S254, https://doi.org/
b. 10.1148/radiographics.21.suppl_1.g01oc18s237.
N. Griffin, ME Gore, SA Sohaib, Imaging in metastatic renal cell carcinoma, AJR Am. J. Roentgenol. 189 (2007) 360–370, https://doi.org/10.2214/ AJR.07.2077.
DM Coll, BR Herts, WJ Davros, RG Uzzo, AC Novick, Preoperative use of 3D volume rendering to demonstrate renal tumors and renal anatomy, Radiographics 20 (2000) 431– 438, https://doi.org/10.1148/radiographics.20.2.g00mc16431.
F. Rocco, LA Cozzi, G. Cozzi, Study of the renal segmental arterial anatomy with contrastenhanced multi-detector computed tomography, Surg. Radiol. Anat. 37 (2015) 517–526, https://doi.org/10.1007/s00276-014-1382-7.
S. Donat, M. Diaz, J. Bishoff, JA Coleman, P. Dahm, IH Derweesh, S. Duke Herrell 3rd, S. Hilton, E. Jonasch, DW Lin, VE Reuter, SS Chang, Follow-up for clinically localized renal neoplasms AUA guideline, J. Urol. 190 (2013) 407–416, https://doi.org/10.1016/j.juro.2013.04.121.
ESUR Guidelines on Contrast Agents v.10, European Society of Urogenital Radiology, 2021. www.esur-cm.org.
ZJ Wang, MS Davenport, SG Silverman, H. Chandarana, A. Doshi, GM Israel, JR
a. Leyendecker, I. Pedrosa, S. Raman, EM Remer, AB Shinagare, AD Smith, R. Vikram, MRI Renal Mass Protocol v1.0: Society of Abdominal Radiology Disease Focused Panel on Renal Cell Carcinoma, 2020 https://doi.org/ abdominalradiology.org/wpcontent/uploads/2020/11/RCC.MRIprotocolfinal-7- 15-17.pdf.
GM Israel, N. Hindman, MA Bosniak, Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system, Radiology 231 (2004) 365– 371, https://doi.org/10.1148/radiol.2312031025.
AB Rosenkrantz, NE Wehrli, TC Mussi, SS Taneja, MJ Triolo, Complex cystic renal masses: comparison of cyst complexity and Bosniak classification between 1.5 T and 3 T MRI, Eur. J. Radiol. 83 (2014) 503–508, https://doi.org/ 10.1016/j.ejrad.2013.11.013.
NM Hindman, Imaging of cystic renal masses, Urol. Clin. North Am. 45 (2018) 331–349, https://doi.org/10.1016/j.ucl.2018.03.006.
JR Tse, J. Shen, L. Shen, L. Yoon, A. Kamaya, Bosniak classification of cystic renal masses version 2019: comparison of categorization using CT and MRI, AJR Am. J. Roentgenol. 216 (2021) 412–420, https://doi.org/10.2214/ AJR.20.23656.
M. Dilauro, M. Quon, MD McInnes, M. Vakili, A. Chung, TA Flood, N. Schieda, Comparison of contrast- enhanced multiphase renal protocol CT versus MRI for diagnosis of papillary renal cell carcinoma, AJR Am. J. Roentgenol. 206 (2016) 319–325, https://doi.org/10.2214/AJR.15.14932.
N. Schieda, RS Lim, MDF McInnes, I. Thomassin, R. Renard-Penna, S. Tavolaro, FH Cornelis, Characterization of small (<4cm) solid renal masses by computed tomography and magnetic resonance imaging: current evidence and further development, Diagn. Interv. Imaging 99 (2018) 443–455, https://doi.org/ 10.1016/j.diii.2018.03.004.
F. Cornelis, E. Tricaud, AS Lasserre, F. Petitpierre, JC Bernhard, Y. Le Bras, M. Yacoub, M. Bouzgarrou, A. Ravaud, N. Grenier, Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours, Eur. Radiol. 24 (2014) 1068–1080, https://doi.org/ 10.1007/s00330-014-3107-z.
NK Ramamurthy, B. Moosavi, MD McInnes, TA Flood, N. Schieda, Multiparametric MRI of solid renal masses: pearls and pitfalls, Clin. Radiol. 70 (2015) 304–316, https://doi.org/10.1016/j.crad.2014.10.006.
129]MR Sun, L. Ngo, EM Genega, MB Atkins, ME Finn, NM Rofsky, I. Pedrosa, Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypescorrelation with pathologic findings, Radiology 250 (2009) 793–802, https://doi.org/10.1148/radiol.2503080995.
130]JR Young, H. Coy, HJ Kim, M. Douek, P. Lo, AJ Pantuck, SS Raman, Performance of relative enhancement on multiphasic MRI for the differentiation of clear cell renal cell carcinoma (RCC) from papillary and chromophobe RCC subtypes and oncocytoma, AJR Am. J. Roentgenol. 208 (2017) 812–819, https:// doi.org/10.2214/AJR.16.17152.
AB Rosenkrantz, NE Wehrli, J. Melamed, SS Taneja, MB Shaikh, Renal masses measuring under 2 cm: pathologic outcomes and associations with MRI features, Eur. J. Radiol. 83 (2014) 1311–1316, https://doi.org/10.1016/j. ejrad.2014.05.016.
AM Hotker, Y. Mazaheri, A. Wibmer, CA Karlo, J. Zheng, CS Moskowitz, SK Tickoo, P. Russo, H. Hricak, O. Akin, Differentiation of clear cell renal cell carcinoma from other renal cortical tumors by use of a quantitative multiparametric MRI approach, AJR Am. J. Roentgenol. 208 (2017) W85–W91, https://doi.org/10.2214/AJR.16.16652.
C. Roy Sr, S. El Ghali, X. Buy, XV Lindner, H. Lang, C. Saussine, D. Jacqmin, Significance of the pseudocapsule on MRI of renal neoplasms and its potential application for local staging: a retrospective study, AJR Am. J. Roentgenol. 184 (2005) 113–120, https://doi.org/10.2214/ajr.184.1.01840113.
RS Lim, TA Flood, MDF McInnes, LT Lavallee, N. Schieda, Renal angiomyolipoma without visible fat: can we make the diagnosis using CT and MRI? Eur. Radiol. 28 (2018) 542–553, https://doi.org/10.1007/s00330-017- 4988-4.
FU Kay, NE Canvasser, Y. Xi, DF Pinho, DN Costa, A. Diaz de Leon, G. Khatri, JR Leyendecker, T. Yokoo, AH Lay, N. Kavoussi, E. Koseoglu, JA Cadeddu, I. Pedrosa, Diagnostic performance and interreader agreement of a standardized MR imaging approach in the prediction of small renal mass histology, Radiology 287 (2018) 543–553, https://doi.org/10.1148/radiol.2018171557.
C. Roy, B. Sauer, V. Lindner, H. Lang, C. Saussine, D. Jacqmin, MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses, Eur. Radiol. 17 (2007) 193–200, https://doi.org/10.1007/s00330- 006-0271-9.
MR Oliva, JN Glickman, KH Zou, SY Teo, KJ Mortel´e, MS Rocha, SG Silverman, Renal cell carcinoma T1 and T2 signal intensity characteristics of papillary and clear cell types correlated with pathology, AJR Am. J. Roentgenol. 192 (2009) 1524–1530, https://doi.org/10.2214/AJR.08.1727.
JJ Park, CK Kim, Small (< 4 cm) renal tumors with predominantly low signal intensity on T2-Weighted images: differentiation of minimal-fat angiomyolipoma from renal cell carcinoma, AJR Am. J. Roentgenol. 208 (2017) 124–130, https:// doi.org/10.2214/AJR.16.16102
C. Galmiche, JC Bernhard, M. Yacoub, A. Ravaud, N. Grenier, F. Cornelis, Is Multiparametric MRI Useful for Differentiating Oncocytomas From Chromophobe Renal Cell Carcinomas? AJR Am. J. Roentgenol. 208 (2017) 343–350, https://doi. org/10.2214/AJR.16.16832.
EA Lassel, R. Rao, C. Schwenke, SO Schoenberg, HJ Michaely, Diffusionweighted imaging of focal renal lesions: a meta-analysis, Eur. Radiol. 24 (2014) 241–249, https://doi.org/10.1007/s00330-013-3004-x.
M. Tordjman, R. Mali, G. Madelin, V. Prabhu, SK Kang, Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and metaanalysis, Eur. Radiol. 30 (2020) 4023–4038, https://doi.org/ 10.1007/s00330-020-06740-w.
A. Goyal, R. Sharma, AS Bhalla, S. Gamanagatti, A. Seth, VK Iyer, P. Das, Diffusionweighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype, Acta Radiol. 53 (2012) 349–358, https:// doi.org/10.1258/ar.2011.110415.
X. Yu, M. Lin, H. Ouyang, C. Zhou, H. Zhang, Application of ADC measurement in characterization of renal cell carcinomas with different pathological types and grades by 3.0T diffusion-weighted MRI, Eur. J. Radiol. 81 (2012) 3061–3066, https://doi.org/10.1016/j.ejrad.2012.04.028.
E. Inci, E. Hocaoglu, S. Aydin, T. Cimilli, Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification, Eur. J. Radiol. 81 (2012) 815–820, https://doi.org/10.1016/j. ejrad.2011.02.024. AC Tsili et al. European Journal of Radiology 141 (2021) 109777 14
S. Sevcenco, G. Heinz-Peer, L. Ponhold, D. Javor, FE Kuehhas, HC Klingler, M. Remzi, P. Weibl, SF Shariat, PA Baltzer, Utility and limitations of 3-Tesla diffusion-weighted magnetic resonance imaging for differentiation of renal tumors, Eur. J. Radiol. 83 (2014) 909–913, https://doi.org/10.1016/j. ejrad.2014.02.026.
146]KM Krajewski, AB Shinagare, Novel imaging in renal cell carcinoma, Curr. Opin. Urol. 26 (2016) 388–395, https://doi.org/10.1097/ MOU.0000000000000314.
Y. Ding, Q. Tan, W. Mao, D. Chenchen, H. Xiaoyi, H. Jun, Z. Mengsu, Z. Jianjun, Differentiating between malignant and benign renal tumors: do IVIM and diffusion kurtosis imaging perform better than DWI? Eur. Radiol. 29 (2019) 6930–6939, https://doi.org/10.1007/s00330-019-06240-6.
A. Goyal, A. Razik, D. Kandasamy, A. Seth, P. Das, B. Ganeshan, R. Sharma, Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study, Abdom. Radiol. (NY) 44 (2019) 3336–3349, https://doi.org/10.1007/s00261-01902122-z.
JH Min, CK Kim, BK Park, E. Kim, B. Kim, Assessment of renal lesions with blood oxygenation level dependent MRI at 3 T: preliminary experience, AJR Am. J. Roentgenol. 197 (2011) W489–W494, https://doi.org/10.2214/AJR.10.6319.
W. Wang, K. Cao, S. Jin, X. Zhu, J. Ding, W. Peng, Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis, Eur. Radiol. 57 (2020) 5738–5747, https://doi.org/10.1007/s00330-020-06896-5.
E. Cui, Z. Li, C. Ma, Q. Li, Y. Lei, Y. Lan, J. Yu, Z. Zhou, R. Li, W. Long, F. Lin, Predicting the ISUP grade of clear cell renal cell carcinoma with multiparametric MR and multiphase CT radiomics, Eur. Radiol. 30 (2020) 2912–2921, https://doi. org/10.1007/s00330-01906601-1.
HA Ali, MJ Couch, R. Menezes, AJ Evans, A. Finelli, MA Jewett, KS Jhaveri, Predictive value of in vivo MR spectroscopy with semilocalization by adiabatic selective refocusing in differentiating clear cell renal cell carcinoma from other subtypes, AJR Am. J. Roentgenol. 214 (2020) 817–824, https://doi.org/10.2214/ AJR.19.22023.
R. Papalia, V. Panebianco, R. Mastroianni, M. Del Monte, E. Altobelli, E. Faiella, FR Grasso, M. Bellangino, G. Simone, M. Ciccozzi, S. Angeletti, G. D'ovidio, C. Catalano, M. Gallucci, RM Scarpa, G. Muto, Accuracy of magnetic resonance imaging to identify pseudocapsule invasion in renal tumors, World J. Urol. 38 (2020) 407–415, https://doi.org/10.1007/s00345-019-02755-1.
LC Adams, B. Ralla, YY Bender, K. Bressem, B. Hamm, J. Busch, F. Fuller, MR Makowski, Renal cell carcinoma with venous extension: prediction of inferior vena cava invasion by MRI, Cancer Imaging 18 (2018) 17, https://doi.org/ 10.1186/s40644-018-0150-z.
ME Krokidis, P. Kitrou, S. Spiliopoulos, K. Karnabatidis, K. Katsanos, Imageguided minimally invasive treatment for small renal cell carcinoma, Insights Imaging 9 (2018) 385– 390, https://doi.org/10.1007/s13244-018-0607-4.
M. Rossi, G. Orgera, A. Hatzidakis, M. Krokidis, Minimally invasive ablation treatment for locally advanced pancreatic adenocarcinoma, Cardiovasc. Intervent. Radiol. 37 (2014) 586– 591, https://doi.org/10.1007/s00270-013- 0724-x.
DA Gervais, FJ McGovern, BJ Wood, SN Goldberg, WS McDougal, PR Mueller, Radiofrequency ablation of renal cell carcinoma: early clinical experience, Radiology 217 (2000) 665–672, https://doi.org/10.1148/ radiology.217.3.r00dc39665.
LW Organ, Electrophysiologic principles of radiofrequency lesion making, Appl. Neurophysiol. 39 (1976) 69–76, https://doi.org/10.1159/000102478 (1976- 1977).
SP Psutka, AS Feldman, WS McDougal, FJ McGovern, P. Mueller, DA Gervais, Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma, Eur. Urol. 63 (2013) 486–492, https://doi.org/10.1016/j. eururo.2012.08.062.
B. Feng, P. Liang, Local thermal ablation of renal cell carcinoma, Eur. J. Radiol. 81 (2012) 437–440, https://doi.org/10.1016/j.ejrad.2010.12.056.
NE Hoffmann, JC Bischof, The cryobiology of cryosurgical injury, Urology 60 (2002) 40– 49, https://doi.org/10.1016/s0090-4295(02)01683-7.
CS Georgiades, R. Rodriguez, Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study, Cardiovasc. Intervent. Radiol. 37 (2014) 1494–1499, https://doi.org/ 10.1007/s00270-013-0831-8.
T. Kawabata, T. Hiraki, T. Iguchi, Y. Matsui, M. Uka, Y. Masaoka, T. Komaki, J. Sakurai, H. Gobara, M. Araki, Y. Nasu, S. Kanazawa, Post-ablation syndrome after percutaneous cryoablation of small renal tumors: a prospective study of incidence, severity, duration, and effect on lifestyle, Eur. J. Radiol. 122 (2020) 108750, https://doi.org/10.1016/j.ejrad.2019.108750.
J. Yu, G. Zhang, P. Liang, Xl. Yu, Z. Cheng, Z. Han, X. Zhang, J. Dong, Q. Li, M. Mu, X. Li, Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radial nephrectomy for small renal cell carcinoma, Abdom. Imaging 40 (2015) 3248–3256, https://doi. org/10.1007/s00261-015-0500-2.
M. Allasia, F. Soria, A. Battaglia, C. Gazzera, M. Calandri, MP Caprino, B. Lucatello, A. Velrti, M. Maccario, B. Pasini, A. Bosio, P. Gontero, P. Destefanis, Radiofrequency ablation for renal Cancer in von hippel-lindau syndrome patients: a prospective cohort analysis, Clin. Genitourin. Cancer 10 (2017), https://doi. org/10.1016/j.clgc.2017.07.027. S15587673(17)30237-30239.
M. Krokidis, S. Spiliopoulos, M. Jarzabek, N. Fotiadis, T. Sabharwal, T. O'Brien, A. Adam, Percutaneous radiofrequency ablation of small renal tumours in patients with a single functioning kidney: long-term results, Eur. Radiol. 23 (2013) 1933–1939, https://doi.org/10.1007/s00330-013-2802-5.
R. Hoffmann, TF Jakobs, CH Kubisch, C. Trumm, C. Weber, M. Siebels, TK Helmberger, MF Reiser, Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results, Eur. J. Radiol. 73 (2010) 652–656, https://doi.org/10.1016/j.ejrad.2008.12.015.
S. Mylona, A. Kokkinaki, M. Pomoni, P. Galani, S. Ntai, L. Thanos, Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience, Eur. J. Radiol. 69 (2009) 351–356, https://doi.org/10.1016/j. ejrad.2007.10.004.
A. Uhlig, O. Hahn, A. Strauss, J. Lotz, L. Trojan, R. Müller-Wille, J. Uhlig, Treatment for localized T1a clear cell renal cell carcinoma: survival benefit for cryosurgery and thermal ablation compared to deferred therapy, Cardiovasc. Intervent. Radiol. 41 (2018) 277–283, https://doi.org/10.1007/s00270-017- 1816-9.
R. El Dib, NJ Touma, A. Kapoor, Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies, BJU Int. 110 (2012) 510–516, https://doi.org/10.1111/j.1464-410X.2011.10885.x.
DA Kunkle, RG Uzzo, Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis, Cancer 113 (2008) 2671–2680, https://doi.org/ 10.1002/cncr.23896.
TD Atwell, GD Schmit, SA Boorjian, J. Mandrekar, A. Nicholas Kurup, AJ Weisbrod, GK Chow, BC Leibovich, MR Callstrom, DE Patterson, CM Lohse, R. Houston Thompson, Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation, AJR Am. J. Roentgenol. 200 (2013) 461–466, https://doi.org/10.2214/AJR.12.8618.
NJ Hegarty, IS Gill, MM Desai, EM Remer, CM O'Malley, JH Kaouk, Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation, Urology 68 (2006) 7–13, https://doi.org/10.1016/j. urology.2005.12.049.
AJ Gunn, NS Parikh, S. Bhatia, Society of interventional radiology quality improvement standards on percutaneous ablation in renal cell carcinoma, J. Vasc. Interv. Radiol. 31 (2020) 195–201, https://doi.org/10.1016/j.jvir.2019.11.004.
IJ Patel, S. Rahim, JC Davidson, SE Hanks, AL Tam, T. Gregory Walker, LR Wilkins, R. Sarode, I. Weinberg, Society of Interventional Radiology Consensus Guidelines for the Periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions. Part II: recommendations: endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe, J. Vasc. Interv. Radiol. 30 (2019) 1168– 1184, https://doi.org/10.1016/j. jvir.2019.04.017.
M. Krokidis, C. Tappero, D. Bogdanovic, K. Ziebarth, AC Stamm, Computed tomography guided navigation assisted percutaneous ablation of osteoid osteoma in a 7-year-old patient: the low dose approach, Skeletal Radiol. 46 (2017) 989–993, https://doi.org/10.1007/s00256017-2620-y.
A. Babaei Jandaghi, M. Lebady, AA Zamani, A. Heidarzadeh, A. Monfared, R. Pourghorban, A randomised clinical trial to compare coaxial and noncoaxial techniques in percutaneous core needle biopsy of renal parenchyma, Cardiovasc. Intervent. Radiol. 40 (2017) 106–111, https://doi.org/10.1007/s00270-016- 1466-3.
J. Garnon, RL Cazzato, J. Caudrelier, M. Nouri-Neuville, P. Rao, E. Boatta, N. Ramamurthy,
G. Koch, A. Gangi, Adjunctive thermoprotection during percutaneous thermal ablation procedures: review of current techniques, Cardiovasc. Intervent. Radiol. 42 (2019) 344–357, https://doi.org/10.1007/ s00270-018-2089-7.
X. Li, P. Liang, J. Yu, Y. Xiao-Ling, L. Fang-Yi, C. Zhi-Gang, H. Zhi-Yu, Role of contrastenhanced ultrasound in evaluating the efficiency of ultrasound guided percutaneous microwave ablation in patients with renal cell carcinoma, Radiol. Oncol. 47 (2013) 398– 404, https://doi.org/10.2478/raon-2013-0038.
HJ Lee, HJ Chung, HK Wang, SH Shen, YH Chang, CK Chen, HP Chou, YY Chiou, Evolutionary magnetic resonance appearance of renal cell carcinoma after percutaneous cryoablation, Br. J. Radiol. 89 (2016) 20160151, https://doi. org/10.1259/bjr.20160151.
CJ Weight, JH Kaouk, NJ Hegarty, EM Remer, CM O'Malley, BR Lane, IS Gill, AC Novick, Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors, J. Urol. 179 (2008) 1277–1281, https://doi.org/10.1016/j.juro.2007.11.075.
TM Wah, HC Irving, W. Gregory, J. Cartledge, AD Joyce, PJ Selby, Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours, BJU Int. 113 (2014) 416–428, https://doi.org/10.1111/bju.12349.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
